SLE Plasma Profiling Identifies Unique Signatures of Lupus Nephritis and Discoid Lupus

IL-21 drives expansion and plasma cell differentiation of autoreactive CD11chiT-bet+ B cells in SLE

(2018) Shu Wang et al.   Nature Communications

Personalized Immunomonitoring Uncovers Molecular Networks that Stratify Lupus Patients

(2016) Romain Banchereau et al.   CELL

Cutaneous lupus erythematosus

(2016) Jasmine N. Stannard et al.   CURRENT OPINION IN RHEUMATOLOGY

Interferon α kinoid induces neutralizing anti-interferon α antibodies that decrease the expression of interferon-induced and B cell activation associated transcripts: analysis of extended follow-up data from the interferon α kinoid phase I/II study

(2016) Julie Ducreux et al.   RHEUMATOLOGY

The frequency and outcome of lupus nephritis: results from an international inception cohort study

(2015) John G. Hanly et al.   RHEUMATOLOGY

A subset of CD163+ macrophages displays mixed polarizations in discoid lupus skin

(2015) Benjamin F. Chong et al.   ARTHRITIS RESEARCH & THERAPY

Anti-nucleosome antibodies outperform traditional biomarkers as longitudinal indicators of disease activity in systemic lupus erythematosus

(2014) T. Li et al.   RHEUMATOLOGY

Dominant Th1 and Minimal Th17 Skewing in Discoid Lupus Revealed by Transcriptomic Comparison with Psoriasis

(2013) Ali Jabbari et al.   JOURNAL OF INVESTIGATIVE DERMATOLOGY

Cross-Species Transcriptional Network Analysis Defines Shared Inflammatory Responses in Murine and Human Lupus Nephritis

(2012) C. C. Berthier et al.   JOURNAL OF IMMUNOLOGY

A phase III, randomized, placebo-controlled study of belimumab, a monoclonal antibody that inhibits B lymphocyte stimulator, in patients with systemic lupus erythematosus

(2011) Richard Furie et al.   ARTHRITIS AND RHEUMATISM

Linear immunoglobulin A bullous dermatosis

(2011) Giulio Fortuna et al.   CLINICS IN DERMATOLOGY

Efficacy and safety of belimumab in patients with active systemic lupus erythematosus: a randomised, placebo-controlled, phase 3 trial

(2011) Sandra V Navarra et al.   LANCET

Prolonged Serologically Active Clinically Quiescent Systemic Lupus Erythematosus: Frequency and Outcome

(2010) A. J. STEIMAN et al.   JOURNAL OF RHEUMATOLOGY

Upregulation of TNF Receptor Type 2 in Human and Experimental Renal Allograft Rejection

(2009) U. Hoffmann et al.   AMERICAN JOURNAL OF TRANSPLANTATION

Interferon-regulated chemokines as biomarkers of systemic lupus erythematosus disease activity: A validation study

(2009) Jason W. Bauer et al.   ARTHRITIS AND RHEUMATISM

High-titer antichromatin antibody is associated with proliferative class IV of lupus nephritis

(2008) J. F. Carvalho et al.   CLINICAL RHEUMATOLOGY

A Modular Analysis Framework for Blood Genomics Studies: Application to Systemic Lupus Erythematosus

(2008) Damien Chaussabel et al.   IMMUNITY

Interferon Alpha-Induced Lupus

(2008) Timothy B. Niewold   JCR-JOURNAL OF CLINICAL RHEUMATOLOGY

Revised classification of lupus nephritis is valuable in predicting renal outcome with an indication of the proportion of glomeruli affected by chronic lesions

(2008) N. Hiramatsu et al.   RHEUMATOLOGY